Viewing Study NCT03854032


Ignite Creation Date: 2025-12-24 @ 9:54 PM
Ignite Modification Date: 2026-01-02 @ 1:55 PM
Study NCT ID: NCT03854032
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-06-06
First Post: 2019-02-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck
Sponsor: Thomas Jefferson University
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 18P.771
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View